Brian G Lee, MD - Medicare Critical Care (intensivists) in Washington, DC

Brian G Lee, MD is a medicare enrolled "Internal Medicine - Critical Care Medicine" physician in Washington, District Of Columbia. He went to Yale University School Of Medicine and graduated in 1994 and has 30 years of diverse experience with area of expertise as Critical Care (intensivists). He is a member of the group practice Medstar Medical Group Ii Llc, Medstar Medical Group Ii Llc and his current practice location is 110 Irving St Nw, Rm 4b42, Washington, District Of Columbia. You can reach out to his office (for appointments etc.) via phone at (202) 877-7259.

Brian G Lee is licensed to practice in District Of Columbia (license number MD33686) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1487635512.

Contact Information

Brian G Lee, MD
110 Irving St Nw, Rm 4b42,
Washington, DC 20010-2976
(202) 877-7259
(202) 877-7258



Physician's Profile

Full NameBrian G Lee
GenderMale
SpecialityCritical Care (intensivists)
Experience30 Years
Location110 Irving St Nw, Washington, District Of Columbia
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Brian G Lee attended and graduated from Yale University School Of Medicine in 1994
  NPI Data:
  • NPI Number: 1487635512
  • Provider Enumeration Date: 11/07/2005
  • Last Update Date: 07/08/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 6204965965
  • Enrollment ID: I20100519000248

Medical Identifiers

Medical identifiers for Brian G Lee such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1487635512NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RC0200XInternal Medicine - Critical Care Medicine MD33686 (District Of Columbia)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Medstar Washington Hospital CenterWashington, DCHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Medstar Medical Group Ii Llc05474138251776
Medstar Medical Group Ii Llc05474138251776

News Archive

Magnetic nanoparticles-based method uses saliva to screen DNA polymorphism in stroke patients

C677T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene is a risk factor for stroke. Studies have report a higher C677T homozygosity frequency in Chinese than in Europeans. Usually, the detection of genetic diseases is rather complicated on a large scale owing to the invasive sampling and a cumbersome DNA extraction process.

Intra-Cellular Therapies ITI-007 Phase Ib/II clinical trial for schizophrenia meets primary endpoint

Intra-Cellular Therapies, Inc. today announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, investigational new drug for the treatment of schizophrenia. The trial met its primary endpoint demonstrating that ITI-007 was safe and well-tolerated in patients with stabilized schizophrenia.

Avexa's ATC Phase III study concludes

Avexa Limited today announced that the apricitabine (ATC) Phase III study will be closed and the data will be subsequently unblinded and analyzed. After extensive interaction with the regulatory authorities and potential partners, the decision was made to evaluate the 24 week data with the results due in the first quarter of 2010.

Thought leaders at U-CARS meeting to explore issues related to heart recovery and regeneration

For many years, the answer to that question was unequivocally "No." But as the University of Utah School of Medicine's annual Utah Cardiac Recovery Symposium will explore on Jan. 12-13, advances in treating heart failure are giving physicians, surgeons and researchers reason to hope the deadly disease might one day be defeated.

Using mindfulness approach to tackle opioid crisis

Boston Medical Center was awarded a multi-million dollar grant from the National Institutes of Health to improve function for chronic lower back pain (cLBP) using a non-pharmacologic approach.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Brian G Lee allows following entities to bill medicare on his behalf.
Entity NameWhc Physician Group Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1700154226
PECOS PAC ID: 6103093513
Enrollment ID: O20120125000252

News Archive

Magnetic nanoparticles-based method uses saliva to screen DNA polymorphism in stroke patients

C677T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene is a risk factor for stroke. Studies have report a higher C677T homozygosity frequency in Chinese than in Europeans. Usually, the detection of genetic diseases is rather complicated on a large scale owing to the invasive sampling and a cumbersome DNA extraction process.

Intra-Cellular Therapies ITI-007 Phase Ib/II clinical trial for schizophrenia meets primary endpoint

Intra-Cellular Therapies, Inc. today announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, investigational new drug for the treatment of schizophrenia. The trial met its primary endpoint demonstrating that ITI-007 was safe and well-tolerated in patients with stabilized schizophrenia.

Avexa's ATC Phase III study concludes

Avexa Limited today announced that the apricitabine (ATC) Phase III study will be closed and the data will be subsequently unblinded and analyzed. After extensive interaction with the regulatory authorities and potential partners, the decision was made to evaluate the 24 week data with the results due in the first quarter of 2010.

Thought leaders at U-CARS meeting to explore issues related to heart recovery and regeneration

For many years, the answer to that question was unequivocally "No." But as the University of Utah School of Medicine's annual Utah Cardiac Recovery Symposium will explore on Jan. 12-13, advances in treating heart failure are giving physicians, surgeons and researchers reason to hope the deadly disease might one day be defeated.

Using mindfulness approach to tackle opioid crisis

Boston Medical Center was awarded a multi-million dollar grant from the National Institutes of Health to improve function for chronic lower back pain (cLBP) using a non-pharmacologic approach.

Read more Medical News

› Verified 5 days ago

Entity NameMedstar Medical Group Ii Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1184046187
PECOS PAC ID: 0547413825
Enrollment ID: O20130117000415

News Archive

Magnetic nanoparticles-based method uses saliva to screen DNA polymorphism in stroke patients

C677T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene is a risk factor for stroke. Studies have report a higher C677T homozygosity frequency in Chinese than in Europeans. Usually, the detection of genetic diseases is rather complicated on a large scale owing to the invasive sampling and a cumbersome DNA extraction process.

Intra-Cellular Therapies ITI-007 Phase Ib/II clinical trial for schizophrenia meets primary endpoint

Intra-Cellular Therapies, Inc. today announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, investigational new drug for the treatment of schizophrenia. The trial met its primary endpoint demonstrating that ITI-007 was safe and well-tolerated in patients with stabilized schizophrenia.

Avexa's ATC Phase III study concludes

Avexa Limited today announced that the apricitabine (ATC) Phase III study will be closed and the data will be subsequently unblinded and analyzed. After extensive interaction with the regulatory authorities and potential partners, the decision was made to evaluate the 24 week data with the results due in the first quarter of 2010.

Thought leaders at U-CARS meeting to explore issues related to heart recovery and regeneration

For many years, the answer to that question was unequivocally "No." But as the University of Utah School of Medicine's annual Utah Cardiac Recovery Symposium will explore on Jan. 12-13, advances in treating heart failure are giving physicians, surgeons and researchers reason to hope the deadly disease might one day be defeated.

Using mindfulness approach to tackle opioid crisis

Boston Medical Center was awarded a multi-million dollar grant from the National Institutes of Health to improve function for chronic lower back pain (cLBP) using a non-pharmacologic approach.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Brian G Lee is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Brian G Lee, MD
1201 Seven Locks Rd, Suite 200,
Rockville, MD 20854-2931

Ph: (301) 652-5771
Brian G Lee, MD
110 Irving St Nw, Rm 4b42,
Washington, DC 20010-2976

Ph: (202) 877-7259

News Archive

Magnetic nanoparticles-based method uses saliva to screen DNA polymorphism in stroke patients

C677T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene is a risk factor for stroke. Studies have report a higher C677T homozygosity frequency in Chinese than in Europeans. Usually, the detection of genetic diseases is rather complicated on a large scale owing to the invasive sampling and a cumbersome DNA extraction process.

Intra-Cellular Therapies ITI-007 Phase Ib/II clinical trial for schizophrenia meets primary endpoint

Intra-Cellular Therapies, Inc. today announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, investigational new drug for the treatment of schizophrenia. The trial met its primary endpoint demonstrating that ITI-007 was safe and well-tolerated in patients with stabilized schizophrenia.

Avexa's ATC Phase III study concludes

Avexa Limited today announced that the apricitabine (ATC) Phase III study will be closed and the data will be subsequently unblinded and analyzed. After extensive interaction with the regulatory authorities and potential partners, the decision was made to evaluate the 24 week data with the results due in the first quarter of 2010.

Thought leaders at U-CARS meeting to explore issues related to heart recovery and regeneration

For many years, the answer to that question was unequivocally "No." But as the University of Utah School of Medicine's annual Utah Cardiac Recovery Symposium will explore on Jan. 12-13, advances in treating heart failure are giving physicians, surgeons and researchers reason to hope the deadly disease might one day be defeated.

Using mindfulness approach to tackle opioid crisis

Boston Medical Center was awarded a multi-million dollar grant from the National Institutes of Health to improve function for chronic lower back pain (cLBP) using a non-pharmacologic approach.

Read more News

› Verified 5 days ago


Internal Medicine Doctors in Washington, DC

Dr. Adefolaju Oketokun, MD
Critical Care Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1629 K Street Nw, Suite 300, Washington, DC 20006
Phone: 202-636-1360    Fax: 202-636-5137
Dr. Uzoamaka Theodora Nwaogwugwu, MD
Critical Care Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 2041 Georgia Avenue Nw, Washington, DC 20060
Phone: 202-865-7677    
Ms. Sruthi Nukalapati Reddy, M.D.
Critical Care Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 3800 Reservoir Road Nw, 6 Phc, Washington, DC 20007
Phone: 202-444-8123    
Dr. Kaustubh Subhash Yadwadkar, M.D.
Critical Care Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 3800 Reservoir Rd Nw, Cg201, Washington, DC 20007
Phone: 304-206-7595    
Dr. Monica Vohra, M.D.
Critical Care Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1525 7th St Nw, Washington, DC 20001
Phone: 202-386-7020    Fax: 202-265-1970
Anteneh A Tesfaye, MD
Critical Care Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 110 Irving St Nw Ste C2151, Washington, DC 20010
Phone: 202-877-6998    Fax: 202-877-8909
Erica Nakajima,
Critical Care Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 5255 Loughboro Rd Nw Fl 1, Washington, DC 20016
Phone: 202-660-6500    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.